Related Experiment Video
Updated: Sep 28, 2025
10:40
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
2.5K
Interplay between the Cannabinoid System and microRNAs in Cancer
Julia M Salamat1, Kodye L Abbott2, Patrick C Flannery3
1Department of Anatomy, Physiology and Pharmacology, Auburn University, Auburn, Alabama 36849, United States.
ACS Omega
|April 6, 2022
Summary
Cannabinoids show dual effects in cancer, promoting or inhibiting tumor growth depending on cancer type. Understanding the interplay between cannabinoids and microRNAs (miRNAs) is crucial for predicting and improving cancer patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Cancer patients frequently use cannabinoids for symptom management during treatment.
- Cannabinoids exhibit variable effects on cancer, potentially promoting or inhibiting tumor growth.
- The mechanisms behind these differential cannabinoid effects in various cancer types remain unclear.
Purpose of the Study:
- To investigate the poorly understood interplay between the cannabinoid system and microRNAs (miRNAs) in cancer.
- To elucidate the mechanisms underlying the differential effects of cannabinoids in cancer pathogenesis and treatment response.
- To explore how understanding these interactions can improve cancer patient prognosis.
Main Methods:
- Review of existing literature on cannabinoid effects in cancer.
- Analysis of the role of miRNAs in cancer hallmarks and therapy response.
- Exploration of potential molecular interactions between cannabinoid signaling and miRNA regulation.
Main Results:
- Cannabinoids can have both beneficial (anticancer) and adverse (oncogenic) effects.
- miRNAs are implicated in cancer progression and response to therapy.
- The interaction between cannabinoid system and miRNAs significantly influences cancer outcomes.
Conclusions:
- The differential effects of cannabinoids in cancer are complex and not fully understood.
- Investigating the cannabinoid-miRNA axis offers novel insights into cancer biology.
- Targeting this interaction may lead to improved cancer treatment strategies and patient prognosis.
More Related Videos
Related Concept Videos
01:22MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
01:19Interactions Between Signaling Pathways
6.6K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
01:06Induced Pluripotent Stem Cells
4.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.4K
02:53Adaptive Mechanisms in Cancer Cells
6.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
379
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
379